Tamoxifen induces ACD in breast cancer cells in association with Akt downregulation; conversely, autophagy is involved in tamoxifen resistance via the activation of the PI3K/Akt/mammalian target of rapamycin (mTOR) signaling pathway [69]. This evidence concerns the gene AKT1 and breast carcinoma.